Skip to main content


Front. Endocrinol., 09 April 2019
Sec. Experimental Endocrinology
This article is part of the Research Topic Cross Talk Between The Immune System and Metabolism View all 14 articles

Corrigendum: Role of Hippocampal Lipocalin-2 in Experimental Diabetic Encephalopathy

\r\nAnup Bhusal&#x;Anup Bhusal1Md Habibur Rahman&#x;Md Habibur Rahman1In-Kyu LeeIn-Kyu Lee2Kyoungho Suk,*Kyoungho Suk1,3*
  • 1BK21 Plus KNU Biomedical Convergence Program, Departments of Biomedical Science and Pharmacology, School of Medicine, Kyungpook National University, Daegu, South Korea
  • 2Division of Endocrinology and Metabolism, Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, South Korea
  • 3Brain Science and Engineering Institute, Kyungpook National University, Daegu, South Korea

A Corrigendum on
Role of Hippocampal Lipocalin-2 in Experimental Diabetic Encephalopathy

by Bhusal, A., Rahman, M. H., Lee, I.-K., and Suk, K. (2019). Front. Endocrinol. 10:25. doi: 10.3389/fendo.2019.00025

In the original article, there was a mistake in Figure 1 as published. The Gapdh band image used in Figure 1C was from the pilot experiment. The corrected Figure 1 appears below.


Figure 1. Expression of LCN2 in the hippocampus of diabetic mice. The expression of Lcn2 mRNA in the hippocampus at 8 w post MLDS and 4 w post HDS injection was assessed by conventional PCR (A,C). Further, the expression level of LCN2 protein in the hippocampus of STZ-induced diabetic mice was estimated by ELISA assay (B,D). Similar upregulation of Lcn2 mRNA and LCN2 protein was detected in the hippocampus at 24 w post HFD feeding (E,F). *p < 0.05 vs. the vehicle-treated control animals; Student's t-test; n = 3 for each group; data are represented as mean ± SEM. STZ, streptozotocin; MLDS, multiple low dose of STZ; HDS, high dose of STZ; HFD, high fat diet; LCN2, Lipocalin-2; w, weeks; SEM, standard error of the mean.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: Lipocalin-2, diabetic encephalopathy, hippocampus, glia, neuroinflammation, cognitive dysfunction

Citation: Bhusal A, Rahman MH, Lee I-K and Suk K (2019) Corrigendum: Role of Hippocampal Lipocalin-2 in Experimental Diabetic Encephalopathy. Front. Endocrinol. 10:239. doi: 10.3389/fendo.2019.00239

Received: 25 March 2019; Accepted: 26 March 2019;
Published: 09 April 2019.

Approved by: Frontiers in Endocrinology Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2019 Bhusal, Rahman, Lee and Suk. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Kyoungho Suk,

These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.